Romanian Society of Pharmaceutical Sciences

« Back to Farmacia Journal 1/2017

PREVENTING CARDIAC COMPLICATIONS AFTER NON-CARDIAC NON-VASCULAR SURGERY BY USING PERIOPERATIVE STATIN THERAPY – A PROSPECTIVE STUDY IN CONSTANTA COUNTY, ROMANIA

IRINEL-RALUCA PAREPA 1#*, ANDRA-IULIA SUCEVEANU 1#, LAURA MAZILU 1#, AQEL MOHAMED 2#, DANIEL NIŢĂ 2#, LILIANA-ANA TUŢĂ 1#

1."Ovidius" University, Faculty of Medicine, Constanţa, Romania
2.“Vasile Cândea” Army Centre for Cardiovascular Diseases, Bucharest, Romania

Download Full Article PDF

The aim of the study was to evaluate if statins reduce the risk of cardiac events when given during perioperative period in patients who undergo non-cardiac, non-vascular surgery. 1,380 “statin-naive” patients with no evidence of cardiac disease were randomised for: rosuvastatin 10 mg/day (n = 691), and placebo (n = 689), given 10 days before and 20 days after surgery and were followed-up 3 months after surgery. Endpoint was defined as new-onset angina, silent cardiac ischemia, non-fatal acute coronary syndrome or fatal coronary heart disease. 82 patients (5.95%) suffered cardiac events during follow-up: 31 from statin arm and 51 from placebo arm (p = 0.0029). After adjusting for variables, the statin arm had a relative-risk reduction of 39% (p = 0.0189) for cardiac events. No significant decrease in LDL-cholesterol was found in statin patients (p = 0.5664). Perioperative statin therapy was protective against cardiac complications of non-cardiac non-vascular surgery, irrespective of its lipid-lowering effect.